ATLAS fair value
DKK 235.00
Above fair value · 159% premium
ChemoMetec stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Nasdaq Copenhagen · Denmark
Prices as of Oct 27, 2026 · DKK
DKK 235.00
Above fair value · 159% premium
49%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates ChemoMetec's fair value at about DKK 235.00 per share (reasonable range: DKK 178.37 to DKK 309.61). At DKK 608.00, the stock trades 159% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives ChemoMetec a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between DKK 560.66 and DKK 655.69; in 9 out of 10, between DKK 488.01 and DKK 753.30. Estimated annual volatility is 42%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. ChemoMetec sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks CHEMM.CO has traded between DKK 235.20 and DKK 804.00. Today it is 24.4% below that high and 159% above its low.
On the business: net margin is 39.5%; it trades at 49.7 times earnings.
Its beta is 1.37: it tends to move more than the market, both up and down.
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
Want to see everything about ChemoMetec?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About DKK 235.00 per share according to ATLAS (reasonable range: DKK 178.37 to DKK 309.61). With the stock at DKK 608.00, it is 159% above it.
49%: close to a coin flip. In half of the simulated outcomes, CHEMM.CO ends the month between DKK 560.66 and DKK 655.69.
ChemoMetec's market capitalization is DKK 10.0B. Its price-to-earnings (P/E) ratio is 49.7: you pay DKK 49.7 for each DKK 1.00 of yearly earnings.
ATLAS estimates annual volatility at 42%. In a typical month, half of the outcomes end between DKK 560.66 and DKK 655.69.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy